LIVZON PHARMA(01513) reported a net profit attributable to shareholders of RMB 1.288 billion for the first three quarters, down 26.57% year on year.
LIVZON PHARMA (01513) announced that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year on year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year on year; basic earnings per share were RMB 1.45.
LIVZON PHARMA(01513) announced that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year on year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year on year; basic earnings per share were RMB 1.45.
Related Articles
INSPUR DIGI ENT (00596) repurchased 100,000 shares for HK$162,900 on October 23.
MEGA GENOMICS (06667) repurchased 73,000 shares on October 23 for approximately HK$524,800.
UNISOUND (09678) repurchased 20,000 shares on October 23 for HK$1.075 million.
INSPUR DIGI ENT (00596) repurchased 100,000 shares for HK$162,900 on October 23.
MEGA GENOMICS (06667) repurchased 73,000 shares on October 23 for approximately HK$524,800.
UNISOUND (09678) repurchased 20,000 shares on October 23 for HK$1.075 million.
